ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd (RGC)

5,45
-0,07
(-1,27%)
Fermé 12 Décembre 10:00PM
5,45
0,00
( 0,00% )
Avant marché: 1:00PM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
5,45
Prix Achat
5,00
Prix Vente
6,23
Volume échangé
-
0,00 Fourchette du Jour 0,00
3,00 Plage de 52 semaines 32,44
Cap du marché
Clôture Veille
5,45
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
118 739
Actions en circulation
13 012 866
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-16,49
Bénéfice par action (BPA)
-0,33
Chiffre d'affairess
-
Bénéfice net
-4,3M

À propos de Regencell Bioscience Holdings Ltd

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration. Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Secteur
Medicinal Chems,botanicl Pds
Industrie
Medicinal Chems,botanicl Pds
Siège social
Hong Kong, Hkg
Fondé
-
Regencell Bioscience Holdings Ltd est coté dans le secteur Medicinal Chems,botanicl Pds de la NASDAQ avec le ticker RGC. Le dernier cours de clôture d'Regencell Bioscience était de US$5,45. Au cours de la dernière année, les actions de Regencell Bioscience ont été négociées dans une fourchette de prix de US$ 3,00 à US$ 32,44.

Regencell Bioscience compte actuellement 13 012 866 actions en circulation. La capitalisation boursière d'Regencell Bioscience est de US$70,92 million. Regencell Bioscience a un ratio cours/bénéfice (ratio PE) de -16.49.

RGC Dernières nouvelles

Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy Trial

- The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body and neurodevelopmental conditions...

Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period

Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial   EARTH Efficacy Trials Period of trial 30 January 2022 – 31 March 2022 (EARTH-B Trial) 1 October 2021 – 31...

Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional...

Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional...

Market Report Released for Remainder of Summer

LAS VEGAS, July 20 /PRNewswire/ -- SmallCapSentinel.com has just released an article addressing the market direction over the next 60 days, fusing bull, bearish and flat market perspectives into...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.15-2.678571428575.66.15.41233465.70112CS
4-0.72-11.66936790926.176.715.4670516.02305535CS
12-0.89-14.03785488966.3412.54.181187396.32882572CS
260.6814.25576519924.7732.4431518659.72623035CS
52-4.94-47.545717035610.3932.443778249.65173617CS
156-22.83-80.728429985928.2848.2933021912.42335291CS
260-6.55-54.5833333333125938894126.11868905CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PALIPalisade Bio Inc
US$ 2,90
(107,14%)
26,01M
TRVITrevi Therapeutics Inc
US$ 4,48
(79,92%)
15M
LAESSEALSQ Corporation
US$ 1,70
(47,83%)
31,13M
SYTASiyata Mobile Inc
US$ 0,9914
(32,54%)
19,93M
ATLNAtlantic International Corporation
US$ 7,00
(22,74%)
134
SPGCSacks Parente Golf Inc
US$ 0,265
(-81,07%)
2,47M
KROSKeros Therapeutics Inc
US$ 18,37
(-73,24%)
1,57M
AVGRAvinger Inc
US$ 0,43
(-47,56%)
183,39k
TFFPTFF Pharmaceuticals Inc
US$ 0,0854
(-47,51%)
977,84k
BCTXBriaCell Therapeutics Corporation
US$ 0,6801
(-38,17%)
1,42M
CDTConduit Pharmaceuticals Inc
US$ 0,1064
(20,50%)
53,34M
LAESSEALSQ Corporation
US$ 1,69
(46,96%)
31,26M
PALIPalisade Bio Inc
US$ 2,91
(107,86%)
26,01M
SYTASiyata Mobile Inc
US$ 0,9905
(32,42%)
19,93M
AMPGAmplitech Group Inc
US$ 2,21
(14,51%)
16,29M
Aucune Discussion Trouvée
Ajouter une Discussion